StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.45−0.05 (-3.33%)

Close on Nov 18, 2026Market cap $21.92MP/E –Yield –

CervoMed price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

CervoMed's price to book ratio was 1.0× on Nov 11, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 0.4× to 177.5×, with a median of 2.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.0×−1.8
2025Dec 31, 20252.8×+2.4
2024Dec 31, 20240.4×−4.1
2023Dec 29, 20234.5×+3.9
2022Dec 30, 20220.6×−61.5
2021Dec 31, 202162.1×−71.6
2020Dec 31, 2020133.7×+121.7
2019Dec 31, 201912.0×−12.1
2018Dec 31, 201824.1×−177.9
2017Dec 29, 2017201.9×+49.3
2016Dec 30, 2016152.7×+50.2
2015Apr 30, 2015102.4×−4.6
2014Dec 31, 2014107.0×−310.7
2011Oct 31, 2011417.7×–

More CervoMed figures

See a number that looks wrong?